financetom
Business
financetom
/
Business
/
What's Going On With FiscalNote Holdings Stock Monday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With FiscalNote Holdings Stock Monday?
Feb 24, 2025 8:01 AM

FiscalNote Holdings Inc ( NOTE ) shares are trading higher Monday after the company announced a deal to divest two non-core assets for $40 million.

What Happened: FiscalNote ( NOTE ) entered into a definitive agreement to divest two portfolio companies within its Global Intelligence business, Oxford Analytica and Dragonfly, to Dow Jones for a total consideration of $40 million.

The deal will help FiscalNote ( NOTE ) reduce its senior term loan and strengthen its balance sheet while further simplifying the company’s business. The transaction is expected to close in the first quarter of 2025.

“This divestiture enables us to pay down a significant portion of our senior term loan, resulting in a cumulative paydown of more than 60 percent in the past year,” said Josh Resnik, president and CEO of FiscalNote ( NOTE ).

“Beyond strengthening our financial position, this move will streamline operations, expand Adjusted EBITDA margins, and accelerate our path to positive free cash flow. It also will further sharpen our focus on our core Policy solutions – including PolicyNote, our cutting-edge AI-powered policy management solution – to drive growth.”

See Also: Apple Commits $500 Billion In US Investment For AI Push, Boost US Manufacturing Tech

FiscalNote ( NOTE ) also announced that it engaged former head of contracts for Palantir’s U.S. government vertical John Lee as a senior strategic advisor.

Lee is expected to help support FiscalNote’s mission to provide the public sector with AI and data-driven solutions that enhance operational efficiency, responsiveness and decision-making.

“FiscalNote empowers government entities to operate more efficiently by driving cost savings, improved transparency, and better outcomes for taxpayers,” Resnik said.

“John’s expertise in bringing next-generation technology to the federal government aligns perfectly with FiscalNote’s ongoing efforts to empower decision-makers with efficient, AI-powered insights that streamline and optimize complex government operations.” 

NOTE Price Action: FiscalNote ( NOTE ) shares were up 1.79% at $1.42 at the time of publication Monday, according to Benzinga Pro.

This illustration was generated using artificial intelligence via Midjourney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved